04/09/2024
3:31 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
Wu Charles C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/08/2024
5:03 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
Wu Charles C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/05/2024
4:40 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
Wu Charles C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
4:27 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
Wu Charles C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/02/2024
4:35 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
Wu Charles C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/01/2024
5:42 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
USMAN NASSIM (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/27/2024
8:00 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
|
03/27/2024
3:31 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/27/2024
3:31 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2024
4:03 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
8:55 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2024
7:27 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Nussbaum Rodney L (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/21/2024
7:31 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Nussbaum Rodney L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
6:15 AM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
4:29 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
USMAN NASSIM (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
4:16 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
12:18 PM | GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
LYTTON LAURENCE W (Filed by)
| Form SC 13G/A | |
01/19/2024
3:05 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K/A | |
01/12/2024
3:01 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K/A | |
11/22/2023
6:55 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Luo Ying (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
6:40 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
6:49 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ye Weiguo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
6:34 PM | Chen Ruoyu (Reporting)
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
6:20 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Wu Charles C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
6:27 PM | GNI Group Ltd. (Reporting)
GNI USA, Inc. (Reporting)
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
6:06 PM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 3/A | |
11/13/2023
4:13 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
11/13/2023
6:01 AM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
5:06 AM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2023
4:18 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 424B3 | |
11/01/2023
3:58 PM | GNI Group Ltd. (Filed by)
GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
| Form SC 13D/A | |
11/01/2023
5:07 AM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Wu Charles C (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/01/2023
5:07 AM | Chen Ruoyu (Reporting)
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/01/2023
5:07 AM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ye Weiguo (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/01/2023
5:07 AM | Carmichael Gordon (Reporting)
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/01/2023
5:07 AM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ying Han (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/01/2023
5:07 AM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Parry Renate (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/01/2023
5:07 AM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/01/2023
5:15 AM | Carmichael Gordon (Reporting)
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2023
5:15 AM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Ying Han (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2023
5:15 AM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
USMAN NASSIM (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
A new way to collect income from stocks (Ad) Most people think of BUYING options when they talk about options.
It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time.
The problem is - they don’t always pay off when you buy them.
In fact, a contributing writer at the Financial Post studied options extensively…  Click here to see me place one of these trades LIVE on camera. |
11/01/2023
5:15 AM | Chen Ruoyu (Reporting)
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2023
5:15 AM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Parry Renate (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2023
5:15 AM | Eastling Thomas Wilson (Reporting)
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2023
5:15 AM | GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
Luo Ying (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2023
8:56 PM | GNI Group Ltd. (Reporting)
GNI USA, Inc. (Reporting)
GYRE THERAPEUTICS, INC. (Issuer)
Gyre Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2023
6:28 PM | GNI Group Ltd. (Filed by)
GYRE THERAPEUTICS, INC. (Subject)
Gyre Therapeutics (Subject)
| Form SC 13D/A | |
10/30/2023
4:17 PM | GYRE THERAPEUTICS, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2023
11:15 PM | CATALYST BIOSCIENCES, INC. (Filer)
Gyre Therapeutics (Filer)
| Form EFFECT | |
10/27/2023
6:56 PM | CATALYST BIOSCIENCES, INC. (Issuer)
Gyre Therapeutics (Issuer)
GNI Hong Kong Ltd (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/27/2023
7:01 PM | CATALYST BIOSCIENCES, INC. (Issuer)
Gyre Therapeutics (Issuer)
GNI Group Ltd. (Reporting)
GNI USA, Inc. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/27/2023
4:27 PM | CATALYST BIOSCIENCES, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/27/2023
4:10 PM | CATALYST BIOSCIENCES, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 424B3 | |
10/26/2023
4:22 PM | CATALYST BIOSCIENCES, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/24/2023
3:08 PM | CATALYST BIOSCIENCES, INC. (Filer)
Gyre Therapeutics (Filer)
| Form S-3/A | |
10/13/2023
3:25 PM | CATALYST BIOSCIENCES, INC. (Filer)
Gyre Therapeutics (Filer)
| Form S-3/A | |
08/14/2023
5:01 AM | CATALYST BIOSCIENCES, INC. (Filer)
Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2023
3:40 PM | CATALYST BIOSCIENCES, INC. (Filer)
Gyre Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
07/20/2023
7:57 AM | CATALYST BIOSCIENCES, INC. (Filer)
Gyre Therapeutics (Filer)
| Form DEFM14A | |
06/26/2023
3:06 PM | CATALYST BIOSCIENCES, INC. (Filer)
Gyre Therapeutics (Filer)
| Form PRER14A | |
05/15/2023
3:02 PM | CATALYST BIOSCIENCES, INC. (Filer)
Gyre Therapeutics (Filer)
| Form PRER14A | |
